Health and Medicine Guide: Chapter 4

Download this guide as a PDF

First, Do No Harm. Reporting About Safety
Once a pharmaceutical product — a drug, vaccine, or medical device — has gone through the different testing phases, and the approval process with regulatory agencies, it hits the market and can be prescribed and sold. Serious adverse events can appear when the product is widely used for the first time by real patients. This relates not only to potential flaws in scientific research and problems related to regulatory approval and reporting in scientific journals. It is also sometimes a matter of numbers: If you test safety on 5,000 patients, an adverse event arising in one of 20,000 will become apparent when many more patients use the product.

Health and Medicine Guide: Preface

Download this guide as a PDF

COVID-19
Investigating health care is complex and challenging. Reporting in this field means reading lengthy documents and getting well-acquainted with medical jargon. Numbers and statistics are also part of the game. Although the learning curve can be steep, in this specialized area of investigative journalism you’ll never run out of stories. Truly global, it’s compelling and engaging.

After 6 Months of COVID-19, What’s Next for Pandemic Reporting?

After six months of the global crisis, investigative journalists find themselves reporting on a precarious and demoralized world, which has seen millions of jobs and more than 775,000 lives lost. In a GIJN webinar titled “Where do we go from here?”, a panel of senior journalists from Bosnia, India, Uganda, and the United States shared tips on the topics now ripe for investigation, as well as areas to improve on.